1. Home
  2. AVO vs KALV Comparison

AVO vs KALV Comparison

Compare AVO & KALV Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Mission Produce Inc.

AVO

Mission Produce Inc.

HOLD

Current Price

$14.38

Market Cap

1.0B

ML Signal

HOLD

Logo KalVista Pharmaceuticals Inc.

KALV

KalVista Pharmaceuticals Inc.

HOLD

Current Price

$19.86

Market Cap

1.0B

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
AVO
KALV
Founded
1983
N/A
Country
United States
United States
Employees
3800
N/A
Industry
Farming/Seeds/Milling
Biotechnology: Pharmaceutical Preparations
Sector
Consumer Staples
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
1.0B
1.0B
IPO Year
2020
2014

Fundamental Metrics

Financial Performance
Metric
AVO
KALV
Price
$14.38
$19.86
Analyst Decision
Strong Buy
Strong Buy
Analyst Count
1
5
Target Price
$17.00
$32.60
AVG Volume (30 Days)
844.4K
1.1M
Earning Date
03-12-2026
05-09-2026
Dividend Yield
N/A
N/A
EPS Growth
1.92
N/A
EPS
N/A
N/A
Revenue
$1,391,200,000.00
$50,000,000.00
Revenue This Year
N/A
$187.19
Revenue Next Year
$2.35
$54.93
P/E Ratio
N/A
N/A
Revenue Growth
12.68
495.66
52 Week Low
$9.60
$9.83
52 Week High
$15.02
$21.31

Technical Indicators

Market Signals
Indicator
AVO
KALV
Relative Strength Index (RSI) 63.81 65.02
Support Level $11.60 $14.66
Resistance Level $15.02 N/A
Average True Range (ATR) 0.52 1.29
MACD 0.18 0.30
Stochastic Oscillator 97.78 77.39

Price Performance

Historical Comparison
AVO
KALV

About AVO Mission Produce Inc.

Mission Produce Inc produces, packs, and distributes mainly Hass avocados to retail, wholesale, and food service customers, offering pre-ripe and ripened fruit tailored to customer specifications through its network of ripening facilities. The Company operates through three segments: Marketing & Distribution, which sources and distributes fruit globally and generates the majority of revenue; International Farming, which owns and operates avocado orchards and supplies fruit mainly to Marketing & Distribution, with operations principally in Peru and Guatemala; and Blueberries, which farms blueberries sold under an exclusive marketing agreement. The Company's operations span Peru, the United States, Guatemala, Mexico, Europe, and Canada.

About KALV KalVista Pharmaceuticals Inc.

KalVista Pharmaceuticals Inc is a pharmaceutical company developing and delivering oral therapies for individuals affected by rare diseases with unmet needs. The company applies its knowledge in the kallikrein-kinin system (KKS) and oral drug discovery to develop small-molecule protease inhibitor medicines to address the needs of patients with diseases driven by plasma kallikrein and Factor XIIa. Its FDA-approved product EKTERLY (sebetralstat) is a novel, orally delivered, small-molecule plasma kallikrein inhibitor for the treatment of acute attacks of hereditary angioedema (HAE) in adult and pediatric patients aged twelve years and older.

Share on Social Networks: